Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 784,513 | 724,508 | 695,420 | 730,518 | 702,468 |
| Cost of Goods | 510,539 | 438,255 | 439,529 | 467,645 | 432,910 |
| Gross Profit | 273,974 | 286,253 | 255,891 | 262,873 | 269,558 |
| Operating Expenses | 204,169 | 175,136 | 156,073 | 187,725 | 181,659 |
| Operating Income | 70,344 | 111,372 | 100,347 | 75,793 | 88,809 |
| Interest Expense | 62,814 | 65,101 | 56,939 | 61,662 | 65,511 |
| Other Income | -12,753 | 5,440 | -5,922 | -29,450 | -7,875 |
| Pre-tax Income | -5,223 | 51,711 | 37,486 | -15,319 | 15,423 |
| Income Tax | -23,355 | 16,101 | 12,868 | 5,423 | 3,666 |
| Net Income Continuous | 18,132 | 35,610 | 24,618 | -20,742 | 11,757 |
| Minority Interests | 15,763 | 13,193 | 12,423 | 10,339 | 11,913 |
| Net Income | $2,369 | $22,417 | $12,195 | $-31,081 | $-156 |
| EPS Basic Total Ops | 0.01 | 0.07 | 0.04 | -0.10 | 0.00 |
| EPS Basic Continuous Ops | 0.06 | 0.11 | 0.08 | -0.07 | 0.04 |
| EPS Diluted Total Ops | 0.01 | 0.07 | 0.04 | -0.10 | 0.00 |
| EPS Diluted Continuous Ops | 0.06 | 0.11 | 0.08 | -0.06 | 0.04 |
| EPS Diluted Before Non-Recurring Items | 0.15 | 0.23 | 0.19 | 0.10 | 0.15 |
| EBITDA(a) | $129,447 | $178,360 | $167,317 | $148,740 | $155,798 |